Global Cardiac Prosthetic Devices Market expected to reach $14.4 billion by 2033 with 8.11% CAGR

From GlobeNewswire: 2024-06-28 01:00:00

The Global Cardiac Prosthetic Devices Market is expected to grow from USD 6.6 Billion in 2023 to USD 14.4 Billion by 2033, with a CAGR of 8.11%. These devices assist the cardiovascular system, improving heart function. The market is driven by rising cardiovascular disease prevalence and minimally invasive surgeries, while high costs and complications hinder growth.

Pacemakers dominate the market with the largest revenue share in 2023, improving heart function for congestive heart failure patients. Hospitals are expected to grow the fastest due to government investment in healthcare infrastructure and a growing number of people with cardiovascular illnesses. North America leads the market, while Asia-Pacific is expected to grow rapidly.

Key players in the market include Abbott Laboratories, Medtronics, Boston Scientific, and LivaNova. Recent developments include Medtronic’s approval in Japan for the Micra AV Transcatheter Pacing System and Abbott’s FDA approval for the Epic Plus and Epic Plus Supra Stented Tissue Valves. The market is segmented by product and end-use, with regional analysis for North America, Europe, Asia-Pacific, South America, and Middle East & Africa.



Read more at GlobeNewswire: Global Cardiac Prosthetic Devices Market Size To Exceed USD